急性心肌梗死合并心源性休克的药物治疗

Drug Therapy of Acute Myocardial Infarction with Cardiogenic Shock

摘要: 急性心肌梗死(acute myocardial infarction, AMI)所致的心源性休克( cardiogenic shock, CS)是心梗患者主要死亡因素之一，其中主要的发病机制为急性心肌梗死后引起急性左右心衰竭、周围血管阻力改变、重要器官供血不足，引发炎性反应，最终多器官功能衰竭。临床治疗中，早期稳定血流动力学、行血运重建是心源性休克的主要治疗方式。

Abstract: Cardiac shock due to acute myocardial infarction is one of the main death factors in patients with myocardial infarction, the primary pathogenesis is that AMI leads to acute cardiac failure, peripheral vascular resistance change, insufficient of blood flow of important organs, inflammatory response, multiple organ failure, it’s important to resist blood press of shock, regain blood supply early.